To test if the large animal model replicates a human manifestation of the dysregulated host immune response leading to coagulopathy due to sepsis, we investigated the level of plasma vimentin and its ability to modulate fibrin polymerization potential. The gene discussed is VIM; the disease is blood coagulation disease.